AI-enabled Imaging Modalities Market Size, Revenue, Trend Report 2026 to 2035
What is AI-enabled Imaging Modalities Market?
Global AI-enabled Imaging Modalities Market Size is valued at USD 3.62 Bn in 2025 and is predicted to reach USD 15.16 Bn by the year 2035 at a 15.9% CAGR during the forecast period for 2026 to 2035.
AI-enabled Imaging Modalities Market Size, Share & Trends Analysis By Modality (X-Ray, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Other Modalities), Application (General Imaging, Specialty Imaging), and Segment Forecasts, 2026 to 2035.
AI-enabled imaging systems combine artificial intelligence with medical imaging technologies to improve diagnostic accuracy, automate image analysis, and streamline clinical processes. These systems use machine learning, deep learning, computer vision, and data analysis to assist radiologists in spotting abnormalities, prioritizing cases, enhancing image quality, and shortening reporting times. AI is increasingly found in imaging techniques like X-ray, CT, MRI, ultrasound, mammography, and nuclear imaging to boost patient care and efficiency.
The rising rates of chronic diseases, the growing need for early and accurate diagnoses, and the increasing pressure on healthcare providers to enhance productivity are pushing the uptake of AI-enabled imaging systems. Healthcare organizations are investing more in AI-driven imaging platforms to lower diagnostic mistakes, increase workflow efficiency, and tackle the shortage of qualified radiologists. Moreover, improvements in cloud computing, digital health infrastructure, and AI algorithms are speeding up market growth in both developed and emerging healthcare systems.
Additionally, the rising use of precision medicine, the growing acceptance of value-based healthcare, and increased investments in medical imaging innovation are opening new growth avenues for the market. Ongoing partnerships between imaging equipment manufacturers, AI software developers, and healthcare providers are likely to further boost market adoption in the coming years.
Competitive Landscape
Which are the Leading Players in AI-enabled Imaging Modalities Market?
- GE HealthCare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems Corporation
- Fujifilm Holdings Corporation
- Samsung Medison
- Hologic Inc.
- Carestream Health
- Agfa-Gevaert Group
- Konica Minolta Inc.
- Aidoc
- Viz.ai
- Qure.ai
- Gleamer
- Lunit Inc.
- Arterys
- HeartFlow Inc.
- Subtle Medical
- Riverain Technologies
- Nanox AI
- RadNet Inc.
- Butterfly Network Inc.
- NVIDIA Corporation
- Tempus AI
- Bayer AG
Market Dynamics
Driver
Growing Adoption of AI-assisted Diagnostic Imaging
The rising use of artificial intelligence in imaging diagnostics will fuel the growth of the AI-enabled imaging market during the forecast period. Hospitals have been using AI tools to help analyze images, automate processes, and ensure accurate diagnoses. Additionally, increased investments in digitalization in healthcare, advancements in imaging technologies, and a focus on accurate diagnostics are boosting market growth. The use of artificial intelligence, cloud computing, and analytics technology is helping healthcare providers offer better services.
Restrain/Challenge
Regulatory Complexity and Data Privacy Concerns
One of the biggest challenges in the AI-powered imaging market is the lengthy approval process for AI-based software and imaging technology. Companies must provide proof of their products' effectiveness and reliability before they can be used commercially. Additionally, issues like patient data safety, cybersecurity, compatibility with hospital management systems and PACS, and the high costs of installing AI-enabled imaging technologies also hinder the adoption of this technology.
Hospitals Segment is Expected to Drive the AI-enabled Imaging Modalities Market
The hospitals segment represented the largest share of the AI-based imaging modality market in 2025. The large number of diagnostic imaging procedures carried out in the hospitals along with the rise in adoption of AI-based solutions to make their processes more efficient and to increase the accuracy of diagnosis is one of the factors fueling the growth of this segment.
Deep Learning Segment is Growing at the Highest Rate in the AI-enabled Imaging Modalities Market
This segment is predicted to witness the highest rate of growth during the forecast period. This is because deep learning technology has the capability of detecting images accurately, thereby making it possible to detect any abnormalities in images obtained through various imaging modalities such as CT, MRI, mammography, ultrasonography, and X-rays.
Why North America Led the AI-enabled Imaging Modalities Market?
North America was the leading geographical segment of the AI-driven imaging modalities market in 2025 due to its well-established health care system, the high penetration rate of artificial intelligence technologies, and substantial funding in developing imaging technology.
The presence of large imaging equipment providers, artificial intelligence software developers, and educational institutions in the area plays a significant role in fast product development and commercialization in the region. Besides, government support in advancing digital health initiatives and positive reimbursement policies alongside the growing use of artificial intelligence in radiology boost the market even more.
Key Development
- May 2025: GE HealthCare added to its portfolio of AI-enabled imaging applications by launching advanced intelligent imaging applications that help in enhancing image reconstruction and clinical decision-making.
April 2025: Siemens Healthineers updated its AI-Rad Companion application suite to include automated image analysis software for CT and MRI scans. - February 2025: Philips Healthcare launched new AI-based MRI and CT imaging systems that provided higher resolution images, fast scanning processes, and clinical decision-making tools.
- October 2024: Qure.ai updated its AI-based algorithms for analyzing chest x-rays and CT images to help detect pulmonary diseases and neuroanatomical changes.
AI-enabled Imaging Modalities Market Report Scope:
| Report Attribute | Specifications |
| Market size value in 2025 | USD 3.62 Bn |
| Revenue forecast in 2035 | USD 15.16 Bn |
| Growth Rate CAGR | CAGR of 15.9% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Modality, Application, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Samsung Medison, Hologic Inc., Carestream Health, Agfa-Gevaert Group, Konica Minolta Inc., Aidoc, Viz.ai, Qure.ai, Gleamer, Lunit Inc., Arterys, HeartFlow Inc., Subtle Medical, Riverain Technologies, Nanox AI, RadNet Inc., Butterfly Network Inc., NVIDIA Corporation, Tempus AI, and Bayer AG. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentations of AI-enabled Imaging Modalities Market :
AI-enabled Imaging Modalities Market by Modality -
- X-Ray
- Ultrasound
- Magnetic Resonance Imaging
- Computed Tomography
- Other Modalities
AI-enabled Imaging Modalities Market by Application-
- General Imaging
- Specialty Imaging
AI-enabled Imaging Modalities Market by Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AI-enabled Imaging Modalities Market Size is valued at USD 3.62 Bn in 2025 and is predicted to reach USD 15.16 Bn by the year 2035
The AI-enabled Imaging Modalities Market is expected to grow at a 15.9% CAGR during the forecast period for 2026 to 2035
GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Samsung Medison, Hologic Inc., Carestream Health, Agfa-Gevaert Group, Konica Minolta Inc., Aidoc, Viz.ai, Qure.ai, Gleamer, Lunit Inc., Arterys, HeartFlow Inc., Subtle Medical, Riverain Technologies, Nanox AI, RadNet Inc., Butterfly Network Inc., NVIDIA Corporation, Tempus AI, Bayer AG. and Others.
AI-enabled Imaging Modalities Market is segmented into Modality, Application, and Other.
North America region is leading the AI-enabled Imaging Modalities Market.